Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 4/20 | 0.42 |
| ▸ | MMP2 | P08253 | 4/20 | 0.42 |
| ▸ | MMP9 | P14780 | 4/20 | 0.42 |
| ▸ | MMP8 | P22894 | 4/20 | 0.42 |
| ▸ | MMP13 | P45452 | 4/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.40 |
| ▸ | BMP1 | P13497 | 1/20 | 0.40 |
| ▸ | NR1D1 | P20393 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6803115 | 0.85 | KCNA5 (0.41) | KMT2ATDP1 | |
| SCHEMBL6800867 | 0.83 | MMP1 (0.43) | MMP1MMP2MMP9MMP8MMP13 | |
| SCHEMBL6799662 | 0.83 | MMP1 (0.47) | MMP1MMP2MMP9MMP8MMP13 | |
| SCHEMBL6802678 | 0.82 | BMP1 (0.46) | MMP1MMP2MMP9MMP8MMP13 | |
| SCHEMBL6798073 | 0.82 | PTPRB (0.44) | KCNH2PTPN1KMT2A | |
| SCHEMBL2593275 | 0.76 | CRHBP (0.54) | KCNH2NR1D1ALDH1A1KMT2A | |
| SCHEMBL16682344 | 0.76 | KCNH2 (0.53) | MMP1MMP2MMP9MMP8MMP13 | |
| SCHEMBL992030 | 0.75 | KCNH2 (0.50) | KCNH2NR1D1ALDH1A1KMT2ATDP1 | |
| SCHEMBL27965202 | 0.74 | MMP1 (0.48) | MMP1MMP2MMP9MMP8MMP13 | |
| SCHEMBL16796534 | 0.73 | KCNH2 (0.50) | KCNH2NR1D1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004074238-A1 | PHENETHYLAMINO SULFAMIC ACIDS | THE PROCTER & GAMBLE COMPANY (US) | 2004-09-02 | — | — | WO | disclosed |
| US-20040167183-A1 | Phenethylamino sulfamic acids | THE PROCTER & GAMBLE COMPANY | 2004-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040167183-A1 | Phenethylamino sulfamic acids | PTPRM, PTPRS, PTPRE | MMP1 857/4885MMP2 630/4885MMP9 2969/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.